Logo image of OPAD

OFFERPAD SOLUTIONS INC (OPAD) Stock Fundamental Analysis

USA - NYSE:OPAD - US67623L3078 - Common Stock

2.35 USD
-0.01 (-0.42%)
Last: 10/31/2025, 10:30:59 AM
Fundamental Rating

2

Overall OPAD gets a fundamental rating of 2 out of 10. We evaluated OPAD against 64 industry peers in the Real Estate Management & Development industry. OPAD has a bad profitability rating. Also its financial health evaluation is rather negative. OPAD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

OPAD had negative earnings in the past year.
In the past year OPAD had a positive cash flow from operations.
In the past 5 years OPAD reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: OPAD reported negative operating cash flow in multiple years.
OPAD Yearly Net Income VS EBIT VS OCF VS FCFOPAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 200M -200M -400M -600M -800M

1.2 Ratios

The Return On Assets of OPAD (-21.20%) is worse than 79.69% of its industry peers.
The Return On Equity of OPAD (-231.60%) is worse than 79.69% of its industry peers.
Industry RankSector Rank
ROA -21.2%
ROE -231.6%
ROIC N/A
ROA(3y)-22.91%
ROA(5y)-14.91%
ROE(3y)-122.51%
ROE(5y)-74.49%
ROIC(3y)N/A
ROIC(5y)N/A
OPAD Yearly ROA, ROE, ROICOPAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

OPAD has a Gross Margin of 8.32%. This is in the lower half of the industry: OPAD underperforms 70.31% of its industry peers.
OPAD's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for OPAD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.96%
GM growth 5YN/A
OPAD Yearly Profit, Operating, Gross MarginsOPAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 -5 10

2

2. Health

2.1 Basic Checks

OPAD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OPAD has been increased compared to 1 year ago.
The debt/assets ratio for OPAD is higher compared to a year ago.
OPAD Yearly Shares OutstandingOPAD Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
OPAD Yearly Total Debt VS Total AssetsOPAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.09, we must say that OPAD is in the distress zone and has some risk of bankruptcy.
OPAD has a Altman-Z score of -0.09. This is in the lower half of the industry: OPAD underperforms 73.44% of its industry peers.
The Debt to FCF ratio of OPAD is 5.01, which is a neutral value as it means it would take OPAD, 5.01 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of OPAD (5.01) is better than 76.56% of its industry peers.
A Debt/Equity ratio of 8.80 is on the high side and indicates that OPAD has dependencies on debt financing.
With a Debt to Equity ratio value of 8.80, OPAD is not doing good in the industry: 84.38% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 8.8
Debt/FCF 5.01
Altman-Z -0.09
ROIC/WACCN/A
WACC9.6%
OPAD Yearly LT Debt VS Equity VS FCFOPAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M -200M -400M -600M -800M

2.3 Liquidity

OPAD has a Current Ratio of 1.09. This is a normal value and indicates that OPAD is financially healthy and should not expect problems in meeting its short term obligations.
OPAD's Current ratio of 1.09 is on the low side compared to the rest of the industry. OPAD is outperformed by 68.75% of its industry peers.
OPAD has a Quick Ratio of 1.09. This is a bad value and indicates that OPAD is not financially healthy enough and could expect problems in meeting its short term obligations.
OPAD has a Quick ratio of 0.16. This is amonst the worse of the industry: OPAD underperforms 89.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 0.16
OPAD Yearly Current Assets VS Current LiabilitesOPAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

OPAD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.57%, which is quite good.
Looking at the last year, OPAD shows a very negative growth in Revenue. The Revenue has decreased by -30.44% in the last year.
Measured over the past years, OPAD shows a very negative growth in Revenue. The Revenue has been decreasing by -23.72% on average per year.
EPS 1Y (TTM)15.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22%
Revenue 1Y (TTM)-30.44%
Revenue growth 3Y-23.72%
Revenue growth 5YN/A
Sales Q2Q%-36.16%

3.2 Future

Based on estimates for the next years, OPAD will show a very strong growth in Earnings Per Share. The EPS will grow by 22.25% on average per year.
Based on estimates for the next years, OPAD will show a quite strong growth in Revenue. The Revenue will grow by 19.49% on average per year.
EPS Next Y27%
EPS Next 2Y29.29%
EPS Next 3Y22.25%
EPS Next 5YN/A
Revenue Next Year-26.88%
Revenue Next 2Y-1.79%
Revenue Next 3Y3.03%
Revenue Next 5Y19.49%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OPAD Yearly Revenue VS EstimatesOPAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
OPAD Yearly EPS VS EstimatesOPAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6 -8 -10

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OPAD. In the last year negative earnings were reported.
Also next year OPAD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OPAD Price Earnings VS Forward Price EarningsOPAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, OPAD is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.67
EV/EBITDA N/A
OPAD Per share dataOPAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

OPAD's earnings are expected to grow with 22.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.29%
EPS Next 3Y22.25%

0

5. Dividend

5.1 Amount

No dividends for OPAD!.
Industry RankSector Rank
Dividend Yield N/A

OFFERPAD SOLUTIONS INC

NYSE:OPAD (10/31/2025, 10:30:59 AM)

2.35

-0.01 (-0.42%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)10-20 2025-10-20
Earnings (Next)02-23 2026-02-23/amc
Inst Owners55.56%
Inst Owner Change-0.05%
Ins Owners22.1%
Ins Owner Change3.11%
Market Cap71.86M
Revenue(TTM)703.35M
Net Income(TTM)-56822000
Analysts48.89
Price Target1.21 (-48.51%)
Short Float %21.66%
Short Ratio0.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.42%
Min EPS beat(2)0.15%
Max EPS beat(2)0.69%
EPS beat(4)2
Avg EPS beat(4)-9.26%
Min EPS beat(4)-28.68%
Max EPS beat(4)0.69%
EPS beat(8)2
Avg EPS beat(8)-16.09%
EPS beat(12)4
Avg EPS beat(12)-23.57%
EPS beat(16)7
Avg EPS beat(16)0.97%
Revenue beat(2)0
Avg Revenue beat(2)-12.43%
Min Revenue beat(2)-12.72%
Max Revenue beat(2)-12.15%
Revenue beat(4)0
Avg Revenue beat(4)-6.78%
Min Revenue beat(4)-12.72%
Max Revenue beat(4)-0.3%
Revenue beat(8)1
Avg Revenue beat(8)-5.77%
Revenue beat(12)5
Avg Revenue beat(12)1.76%
Revenue beat(16)8
Avg Revenue beat(16)3.62%
PT rev (1m)0%
PT rev (3m)10.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.76%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-24.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-15.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.1
P/FCF 1.67
P/OCF 1.46
P/B 2.93
P/tB 2.93
EV/EBITDA N/A
EPS(TTM)-2.06
EYN/A
EPS(NY)-0.74
Fwd EYN/A
FCF(TTM)1.41
FCFY59.92%
OCF(TTM)1.61
OCFY68.44%
SpS23
BVpS0.8
TBVpS0.8
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -21.2%
ROE -231.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.32%
FCFM 6.12%
ROA(3y)-22.91%
ROA(5y)-14.91%
ROE(3y)-122.51%
ROE(5y)-74.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.96%
GM growth 5YN/A
F-Score4
Asset Turnover2.62
Health
Industry RankSector Rank
Debt/Equity 8.8
Debt/FCF 5.01
Debt/EBITDA N/A
Cap/Depr 810.19%
Cap/Sales 0.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 0.16
Altman-Z -0.09
F-Score4
WACC9.6%
ROIC/WACCN/A
Cap/Depr(3y)337.52%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.21%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22%
EPS Next Y27%
EPS Next 2Y29.29%
EPS Next 3Y22.25%
EPS Next 5YN/A
Revenue 1Y (TTM)-30.44%
Revenue growth 3Y-23.72%
Revenue growth 5YN/A
Sales Q2Q%-36.16%
Revenue Next Year-26.88%
Revenue Next 2Y-1.79%
Revenue Next 3Y3.03%
Revenue Next 5Y19.49%
EBIT growth 1Y33.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.06%
EBIT Next 3Y34.37%
EBIT Next 5Y20.79%
FCF growth 1Y-94.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.77%
OCF growth 3YN/A
OCF growth 5YN/A

OFFERPAD SOLUTIONS INC / OPAD FAQ

Can you provide the ChartMill fundamental rating for OFFERPAD SOLUTIONS INC?

ChartMill assigns a fundamental rating of 2 / 10 to OPAD.


What is the valuation status of OFFERPAD SOLUTIONS INC (OPAD) stock?

ChartMill assigns a valuation rating of 2 / 10 to OFFERPAD SOLUTIONS INC (OPAD). This can be considered as Overvalued.


Can you provide the profitability details for OFFERPAD SOLUTIONS INC?

OFFERPAD SOLUTIONS INC (OPAD) has a profitability rating of 1 / 10.


What is the financial health of OFFERPAD SOLUTIONS INC (OPAD) stock?

The financial health rating of OFFERPAD SOLUTIONS INC (OPAD) is 2 / 10.